Clinical Trial Update: Head to Head Trial of Mailed Cologuard to Mailed FIT [NA]

View source ↗

Summary

University of California, San Diego is conducting a head-to-head clinical trial comparing mailed Cologuard (MT-sDNA) to mailed FIT for colorectal cancer screeni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: University of California, San Diego | Conditions: Colorectal Cancer Screening, Fecal Immunochemical Test | NA | Status: ENROLLING_BY_INVITATION